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Adjuvant-free immunization with 
infective filarial larvae as lymphatic 
homing antigen carriers
catherine card1, David S. Wilson2, Sachiko Hirosue1, Marcela Rincon-Restrepo1, 
Alexandre de titta  1, Esra Güç1, Coralie Martin3, Odile Bain3,4, Melody A. Swartz1,2 & 
Witold W. Kilarski  1,2*
Controlled infection with intestinal nematodes has therapeutic potential for preventing the symptoms 
of allergic and autoimmune diseases. Here, we engineered larvae of the filarial nematode Litomosoides 
sigmodontis as a vaccine strategy to induce adaptive immunity against a foreign, crosslinked protein, 
chicken egg ovalbumin (OVA), in the absence of an external adjuvant. The acylation of filarial proteins 
with fluorescent probes or biotin was not immediately detrimental to larval movement and survival, 
which died 3 to 5 days later. At least some of the labeled and skin-inoculated filariae migrated through 
lymphatic vessels to draining lymph nodes. The immunization potential of OVA-biotin-filariae was 
compared to that of an OVA-bound nanoparticulate carrier co-delivered with a CpG adjuvant in a typical 
vaccination scheme. Production of IFNγ and tnfα by restimulated CD4+ cells but not CD8+ confirmed 
the specific ability of filariae to stimulate CD4+ T cells. This alternative method of immunization exploits 
the intrinsic adjuvancy of the attenuated nematode carrier and has the potential to shift the vaccination 
immune response towards cellular immunity.
Here, we show that it is possible to turn infectious L3 larvae of parasitic filaria nematode Litomosoides sigmodontis 
into a single carrier for both a natural filarial adjuvant and a non-filarial chicken protein (ovalbumin, OVA). OVA 
bound to filaria cuticle was carried out to the lymph node, where it induced OVA-specific immunity. Because all 
nematodes share the same mechanism of lymphatic entry any non-parasitic free-living nematode can be used in 
place of potentially hazardous filariae.
Most clinically used vaccines induce Th2-type humoral protection, and the titer of protective antibodies deter-
mines their efficacy1. However, combating metastatic tumors and chronic viral infections requires, among other 
things, the stimulation of Th1-type cellular immunity2. For example, attenuated viral and DNA vaccines that 
specifically stimulate Th1-type responses are currently in clinical trials3, while preclinical trials have shown that 
nanoparticle vaccines can have similar activity as viral and DNA vaccines in mice4. In consequence, there are few 
effective therapies against a large number of intracellular parasites or metastatic cells5. The limited repertoire of 
potential vaccination strategies prompted us to examine an unconventional approach, that is, to use live filaria 
larvae as a carrier of intrinsic adjuvant and antigen of choice.
Lymphatic filariasis is caused by parasitic agents that target the mammalian lymphatic system6. Filariae 
migrate through the pre-nodal afferent lymph and can dwell in the capsular and subcapsular sinuses of lymph 
nodes for up to 15 years; however, only 30% of infected individuals develop clinical disease7–9. One reason for 
the absence of clinical disease is helminth-induced immunosuppression, which hides parasites from detection by 
the immune system10. During chronic infection, parasites induce immunosuppression in the host by activating 
worm antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells (Tregs), resulting in immunotolerance by Th2 
lymphocyte anergy. In addition, the alternative activation of innate immunity occurs in the form of M2 mac-
rophage polarization, which limits infection and tissue damage. Furthermore, a modified Th2 response leads to 
the production of non-nematode-specific polyclonal IgE and anti-inflammatory IgG4 in humans and IgG1 anti-
body isotypes in mice11. The immune system is consequently unable to kill adult lymphatic filariae, but it is also 
prevented from causing inflammatory damage to the lymphatic vessels12.
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Counterintuitively, a large number of microfilariemic individuals with an asymptomatic filarial infection have 
markedly increased flow in the lymphatic system occupied by adult filariae, and lymph vessels remain patent 
as long as the nematodes are alive7. Live adult filariae induce the dilatation and wall hypertrophy of lymphatic 
channels and subcapsular sinusoids, but with nematode death and concomitant opportunistic and recurrent 
bacterial and fungal infections, lymphatic vessels become severely injured and occluded, leading to hydrocele 
and lymphedema9,13. Over time, connective tissue builds up, causing the characteristic symptoms of elephan-
tiasis12. The eventual immune response against the nematode parasite is largely a consequence of the release of 
Wolbachia, a bacterial endosymbiont of filariae14. Wolbachia are invertebrate-specific intracellular bacteria that 
live in obligate mutualistic symbiosis with most filarial parasites, controlling their fertility and development15. 
When released by the necrotic cells of dying filariae, these gram-negative bacteria induce IgG2 and cellular Th1 
and Th17 immune response against its own but also filarial antigens8,16,17.
Hence, Wolbachia can be considered a natural adjuvant for filaria-associated antigens that skews the immune 
response towards a Th1 phenotype16. In addition to the release of intracellular bacteria, unmethylated CpG 
sequences from immature filarial nematode DNA18 might stimulate immune cells via TLR9 and additionally 
promote Th1 immunity, as shown in mice19. Finally, the prolonged release of antigens from decomposing dead 
larvae might act as a particulate adjuvant and stimulate anti-nematode and anti-ovalbumin (OVA) Th2-type 
immunity20. Regardless of the specific adjuvant, the dying larvae induce a Th1-type immune response against 
Wolbachia and their own antigens16. However, aside from a single study showing the mitogenic effect of DNA 
from Caenorhabditis elegans on B cells21, the adjuvant properties of parasitic nematodes remain unexplored in 
the literature.
Here, we exploit the lymphatic homing properties22 of filariae to deploy a customized antigen payload into the 
core of the immune system. The labeling process transformed self-guided skin-to-lymph node infective larvae 
into vaccine carriers. The intrinsic adjuvancy of dying filariae facilitates the stimulation of OVA-specific immu-
nity via the release of nonpathogenic intracellular Wolbachia bacteria17,23, methylated CpG sequences of discretely 
methylated nematode DNA18, or the slow-release of OVA from particulates of the protease-resistant cuticle20,24. 
Furthermore, cuticle collagens are resistant to proteolysis because of the high concentration of unique, nonre-
ducible di- and tri-tyrosine bonds24. This protection from rapid clearance delays the decomposition of large, 
millimeter-sized larvae, providing support for prolonged immune stimulation via the gradual release of particu-
late antigens that can also act as an adjuvant25. Finally, the simultaneous release of antigen and intrinsic adjuvant 
directly in the lymph could farther amplify the immune responses26,27.
Importantly, pathological conditions linked to filariasis are induced only by large adult nematodes and micro-
filariae present in high numbers in the skin or blood during the patent (symptomatic) disease period28, with the 
first stage of the prepatent infection, the migratory period (e.g., before filarial L3 larvae reach their final habitat), 
being entirely asymptomatic29–31. Therefore, the prior attenuation of larvae alone should be sufficient to ensure 
the safety of a potential treatment, eliminating the need to choose a parasite with pre-existing host incompatibility 
(inability to develop a patent, reproductive infection)32.
Results
Intravital labeling of filariae has no immediate detrimental effect on larval behavior. First, 
we verified that the permanent, covalent modification of filarial proteins is not immediately toxic to L. sigmo-
dontis larvae. The modification of amino groups in proteins represents the most straightforward chemistry that 
can be safely performed under physiological conditions of living tissue33. To assess the efficiency of the chem-
ical cross-linking of amino groups in live filarial larvae, we labeled filariae with isothiocyanate derivatives of 
tetramethylrhodamine (TRITC) or fluorescein (FITC) fluorophores. The staining patterns of TRITC and FITC 
were equivalent, but to minimize the phototoxic effect of the filaria-bound fluorophore in ambient light, we 
routinely used TRITC34. The fluorophore labeling of filariae produced a strong signal that was uniform between 
filarial larvae and revealed various anatomical structures of the nematode (Fig. 1a). The intestine begins at the 
mouth opening located at the tip of the nematode and ends at the anus valve, approximately 9/10 the length of the 
body from the tip. In addition to surface proteins being labeled, a structure that is entirely hidden within the body, 
the nerve ring, was also stained with the amine-reactive fluorochromes (Fig. 1b). Despite the strong labeling, the 
chemical modification of the protein amino groups did not noticeably affect filarial behavior in vitro. Similar 
to the unlabeled larvae, the labeled filariae moved vigorously and after sedimentation, participated in a swarm 
(Fig. 1c; Video 1). FITC labeling was indirectly toxic to the filarial larvae, which died rapidly after exposure to 
blue light (Video 2). Therefore, all handling of the labeled larvae was performed in darkness, and when applicable, 
larvae were labeled with red dyes (Alexa Fluor 546- and Alexa Fluor 647-labeled streptavidin).
In mice, filariae overlaid with culture media on the surface of the exposed dermis could probe the exposed 
skin but were unable to enter the dermis (Video 3). When injected intradermally, the labeled filariae migrated 
within the dermis for at least 8 hours (Fig. 1e,f and Videos 4,5). A fraction of these larvae then entered the collect-
ing lymphatics (Fig. 1g–i), identified by their sparse smooth muscle coverage and uneven diameter along the ves-
sel length due to the presence of afferent and narrow trunks and post valve sinuses34 (Fig. 1i). As shown in Fig. 1j 
labeled L3 filariae, also reached a draining parotid lymph node, typically located approximately 3.5 cm away from 
the site of filarial injection35. Within the lymph node, larvae occupied space in the subcapsular sinus (Fig. 1k,l), 
which is the anatomical location typically favored by lymphatic filariae7,9. These results indicate that the chemical 
modification was not immediately toxic to the larvae and did not affect their physiological behavior, as filariae 
were still able to home to lymphatic vessels and migrate within them to the draining lymph node.
Protein conjugation to live filariae. In addition to the potential toxicity of the chemical modification 
of surface proteins, we were concerned about the size of the attached molecules. Size alone can have a detri-
mental effect on physiological functions, for example, through the steric hindrance of large molecules that can 
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Figure 1. Chemical modification of filarial proteins has no adverse effect on filarial physiology. (a) Confocal 
Maximum Intensity Ptojection (MIP) of TRITC-labeled filariae. Labeled larvae were fluorescent and readily 
detectable by fluorescence microscopy. The labeling was uniform between live filariae. (b) MIP image of the 
fluorophore labeling of a larva revealed various anatomical organs of the nematode. The intestine begins with 
the mouth opening located at the tip of the larva and ends at the anus valve approximately 9/10 of the way along 
its length. The nerve ring surrounds the pharynx and is located in front of the asymmetric excretory pore at 
the anterior end of the larva. (c) A swarm of FITC-labeled and actively moving filaria (see also Video 1). For 
consistency, FITC-labeled filariae are shown in red. (d) Exposed ear dorsal dermis with the site of filarial injection. 
Approximately half of the injected filaria remained at the inoculation site 3 hours after injection. Arrowheads point 
to labeled larvae that spread within the skin. (e) MIP images of filaria migrating in the skin. The larva is wrapped 
around the lymphatic collecting vessel. Stationary structures in the skin revealed with basment membrane (BM) 
staining.: a, adipocytes; l, lymphatic collector; v, venule; c, capillary; n, nerve. The arrow points to the valve of 
the lymphatic precollector. (f) MIP image of filaria that left the dermis and entered the subcutaneous muscle 
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disrupt receptor-ligand binding36. Therefore, we explored two different bioorthogonal cross-linking techniques, 
the S-4FB/S-HyNic and amine-reactive-biotin/streptavidin/amine-reactive-biotin systems, which both enable the 
in vivo formation of non-dissolvable bonds between proteins. This approach allowed us to couple antigens and 
filariae after the independent activation of the antigen and the nematode proteins. As with FITC or TRITC labe-
ling, immobilizing OVA-streptavidin protein complexes on filariae did not affect their behavior, and the larvae 
remained active and alive for up to 5 days after in vitro staining (Videos 6,7). In the long term, chemical labeling 
was toxic to larvae, as all filariae died 3 to 5 days after staining. This mortality contrasted that of the unlabeled L. 
sigmodontis that survived in culture for two weeks. Hence, chemical labeling of filariae did not abolish the infec-
tive capability of larvae but did ensure that all nematode parasites would die within the skin or lymphatic system 
before establishing a patent infection, which happens 7 to 9 days after inoculation37.
Prefunctionalizing the larvae with aromatic hydrazines (S-HyNic) and OVA with a corresponding aromatic 
aldehyde (S-4FB) followed by subsequent Schiff base-mediated specific conjugation38 of the activated OVA and 
live larvae resulted in the weak and uneven labeling of filariae, with the larvae containing random high-intensity 
fluorescent patches on their bodies (Fig. 2A). Additionally, the pre-functionalization of filarial proteins with 
S-4FB was immediately toxic to the filaria, with 50% of larvae dying during the labeling process. Injured and 
dying larvae were more intensely labeled than live filariae (immotile larvae in Video 6), which was likely due to 
the loss of the integrity of the cell membrane and exposure of intracellular proteins in necrotic cells.
In contrast, the biotinylation of larval proteins with biotin EZ Link sulfo-N-hydroxysuccinimide ester 
(NHS- biotin) and subsequent crosslinking of biotinylated OVA to filariae by a tetrameric streptavidin linker 
did not noticeably harm the larvae and generally yielded uniform labeling of filariae with biotinylated OVA, 
as determined by the subsequent staining of the filarial larvae-bound OVA with the sequentially applied 
Streptavidin-Alexa Fluor 488 (Fig. 2B, left). Additionally, because of the tetrameric nature of streptavidin, the sec-
ond layer of biotinylated OVA could be bound to the filaria-biotinylated OVA-streptavidin complex. This “sand-
wich” labeling amplified the deposition of total biotinylated OVA on the surface of the larva, as inferred from the 
11-fold increase in signal intensity with the subsequent second staining of biotinylated OVA using differently 
labeled streptavidin (corrected for differences in camera sensitivity and exposure times for different wavelengths, 
Fig. 2B, right). On average, this labeling method immobilized 115 ng of OVA on the surface of a single nematode, 
as determined through the densitometric detection of biotinylated OVA by a Western blot of the filarial lysate.
In contrast to the single-step labeling of larvae with small molecular hydrophobic dyes (FITC and TRITC), 
sandwich labeling enabled proteins deposition only on the filarial cuticle, as internal structures of the larvae 
remained unstained. The dissimilarities in the staining pattern probably reflect the differences in size and hydro-
phobicity between proteins and the fluorescent dyes, which can diffuse freely through cell membranes39 and stain 
proteins inside live filariae.
Additionally, isolated from soil, non-parasitic nematodes of various sizes and trophic behavior could also 
survive intravital labeling22. When delivered tyo the skin, a fraction of free-living nematodes migrated through 
the dermis and enter lymphatic (Supplementary Fig. 1).
OVA-conjugated filariae induce an antigen-specific immune response. OVA-conjugated filariae 
were then inoculated into the mouse dermis to assess the immunization potential of the engineered filaria larvae. 
As a benchmark, we used an established particulate antigen carrier coupled to CpG, a potent vaccine adjuvant 
that agonizes TLR94,40. In mice, CpG activates antigen-presenting cells, such as dendritic cells and B cells, and 
induces the secretion of proinflammatory cytokines, principally interleukin (IL)-12p70 and IL-6, which in turn 
induce potent Th1 and cytotoxic T lymphocyte responses. CpG is currently being evaluated in clinical trials as 
an adjuvant for vaccines against cancer and infectious diseases41. As expected, vaccination with OVA-conjugated 
nanoparticles plus CpG (NP-OVA + CpG) resulted in robust OVA-specific CD4+ and CD8+ T cell responses, as 
measured by the proportion of splenic T cells producing IFN-γ and tumor necrosis factor TNF-α in response to 
OVA restimulation (the strong effect size naive of the 1.33 in CD4+ IFN-γ+ and 1.34 in CD4+ TNF-α+ groups 
compared to the naive mice, Fig. 3A). Importantly, vaccination with OVA-conjugated filariae resulted in strong 
stimulation of worm adjuvancy on OVA-specific CD4+ T cell response (effect size 0.99 in the CD4+ IFN-γ+ group 
and 1.2 in the CD4+TNF-α+ group). This observation is particularly notable because these mice did not receive 
(densely packed parallel BM structures surrounding individual muscle fibers). Subcutaneous lymphatics join the 
dermal lymphatic system before entering the parotid lymph node35. (g) Epifluorescence image of the ear dermis 
stained for collagen IV (green). Two filariae in the lymphatic collectors. Arrowheads point to larval heads. The 
arrow points to the lymphatic valve. (h,i) MIP images of filariae within lymphatic collectors. (i) Only the filaria 
marked with the arrowhead is located within the lymphatic collector. Collectors are distinguished from other 
stationary cutaneous structures by the presence of valves, sparse muscle coverage and the uneven diameter of 
the vessel along its length13. Blue arrows point to the direction of the lymph flow that was inferred from the 
morphology of the collector valves. (j) Epifluorescence image of the labeled filariae that reached the draining 
lymph node 1.5 hours after inoculation in the afferent dermis of the mouse ear. Strongly stained larvae stand out 
from the autofluorescence of the thick lymph node. Arrowheads point to individual larvae. (k) MIP image of the 
lymph node capsule and a single filarial larva. (l) M asking of the collagen IV (cyan) and filaria (red) signal with 
intensity surfaces revealed the subcapsular location of the larva. Inset. The larva is located between two layers of 
the basement membrane of the subcapsular sinus. A-B, E-F, H-I, and K-L - maximum projections of the fixed and 
cleared whole-mount tissue preparations imaged with a confocal microscope; C, D, G, and J - epifluorescence 
images of live surgically exposed (C) skin, or ex vivo images (D, G, and J). Scale bars A-B, E-I, K-L, 50 μm; C-D, G, 
and J, 500 μm.
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any additional adjuvant, which suggests that filariae act as an adjuvant. Although fewer CD4+ T cells responded 
to OVA delivered by filariae than by nanoparticle vaccine, it should be noted that the OVA dose associated with 
filarial nematodes was one-fifth that of the nanoparticle vaccine (4 µg vs. 20 µg, respectively). Not surprisingly, we 
did not observe CD8+ T cell responses in OVA-restimulated T cells from the OVA-filaria group, likely because 
the lysine (K)of the SIINFEKL, the immunodominant MHC class I binding peptide, was masked during the 
amine-reactive biotinylation (Fig. 3B). CD8+ T cell responses were not inhibited in OVA-filaria-vaccinated mice 
as they responded to the soluble components from naive filariae (Fig. 3C). In contrast, lysine of SIINFEKL is 
spared during (bio-incompatible) OVA conjugation to -thiol-OVA, which stimulated both CD4+ and CD8 +T 
cells. CD8+ T cells from OVA-filaria immunized C57BL/6 mice retained normal responses as they could be res-
timulated with the nematode antigens used for the immunization of mice. The absence of a CD8+ T cell immune 
response to the OVA antigen in the filaria-OVA-vaccinated indicated specificity of the OVA-biotin-filariae group 
served as an internal control for the effect of nematodes on OVA-specific immunity and showed that there was no 
bystander or nonspecific sensitization of T cells to OVA by chemically modified filarial nematodes.
To address the possibility that vaccination with OVA alone would induce responses similar to those observed 
following vaccination with worm-OVA, we vaccinated mice with OVA (OVA only) and compared their T cell 
responses to those of naive mice and mice vaccinated with NP-OVA + CpG. Consistent with our previous exper-
iments, NP-OVA + CpG vaccination resulted in robust OVA-specific CD4+ and CD8+ T cell responses, whereas 
naive mice were lacked any observable OVA-specific T cell responses (Supplementary Fig. 2). This allowed us to 
directly compare the results of the current and previous experiments, confirming the need of adjuvcant in OVA 
Th1 immunity (Supplementary note). As expected, compared to naive mice, OVA-only vaccinated mice showed 
no OVA-specific T cell responses, confirming the requirement for an adjuvant to establish T cell immunity.
Discussion
Interest is growing in the use of various helminths, including filariae, to control allergic and autoimmune reac-
tions32. This effort is based on observations that individuals with chronic parasitic nematode infections have 
reduced rates of autoimmune diseases42. The first clinical study testing the hypothesis showed that orally admin-
istered porcine whipworm (Trichuris suis) eggs reduced the severity of symptoms in patients with inflammatory 
bowel disease by inducing Tregs and modulatory cytokine production43. As of 2016, 28 clinical trials were under-
way to test the efficacy of the oral administration of T. suis and the human hookworm (Necator americanus) for 
the treatment of several autoimmune and allergic disorders44. Additionally, various Platyhelminthes, as well as 
filarial nematodes, have been found to prevent the onset or reduce the severity of type 1 diabetes in mice45,46. 
These therapies are concluded with only a speculative understanding of the immunomodulatory mechanism of 
intestinal parasites; therefore, it is not surprising that they produce mixed results47.
Here, we propose an opposite approach; parasitic nematodes are specially modified to elicit an immune 
response against specific, the non-filarial antigen. We demonstrate that parasitic nematode can be chemically 
equipped with an antigen of choice, and together with the intrinsic adjuvant properties of filarial larvae, can be 
used as a complete vaccine carrier that naturally targets the lymphatic system. The adjuvant properties of filarial 
larvae, which depend on particulate antigen release48, CpG or the parallel discharge of intracellular Wolbachia 
bacteria from dying nematode cells17, require in-depth analysis.
The lack of previous reports of using filarial larvae to induce a specific immune response can be partially 
explained by the technical challenges involved in the genetic modification of filaria. The absence of a free-living 
stage that could be used to amplify the number of transfected nematodes is a significant obstacle for introducing 
probes or specific genes such as fluorescent proteins or antigens into parasites49,50. Furthermore, sustaining a 
Figure 2. Bioorthogonal labeling of filariae with OVA protein bound only to the cuticle of larvae. 
Epifluorescence stereomicroscope images. (A) HyNic-4FB-OVA-Alexa 647 labeling produced weak and uneven 
filarial staining between larvae. (B) 2 Left The immobilization of Alexa-488-streptavidin on live filariae. After 
being biotinylated in vivo, larvae were incubated with Alexa-488-streptavidin. The lengthy exposure produced 
the high background intensity of the image. (B) Right. The same stained larvae were incubated with biotinylated 
OVA that was stained with Alexa 647-streptavidin. The second round of labeling produced an 11-fold stronger 
signal than the initial labeling of filarial nematodes (“worms”) with streptavidin-488 shown in (B) (left). In 
contrast to direct FITC or TRITC, streptavidin-OVA labels the nematode cuticle but not its internal anatomical 
structures. Scale bar, 400 µm.
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transgenic colony is difficult because parasites have a complex reproductive cycle with intermediate and definitive 
hosts (hematophagous arthropods and vertebrates, respectively)6. To overcome this limitation, we propose an 
alternative approach that relies on the chemical modification of reactive primary amines present on the epicuticle 
and cuticle of the infective larvae51. This method enables the nonfatal fluorescent labeling of larvae or, with subse-
quent bioorthogonal crosslinking, the immobilization of an antigen on the surface of filarial L3 larvae.
The direct modification of filariae with small-molecule fluorophores is a single-step process that was found 
to produce bright, stable fluorescent labeling. Similarly, the labeling of filariae had no effect on the in vitro move-
ment and survival of larvae for up to 5 days. Labeled filariae were also able to migrate in vivo, invade lymphatic 
vessels, and settle in the draining lymph node, indicating that labeling did not affect their lymphatic homing phe-
notype. The absence of direct protein-labeling toxicity is consistent with the findings of previous reports in which 
Figure 3. OVA-conjugated filariae induce OVA-specific T cell responses. Splenocytes were isolated from naive 
mice or mice vaccinated with either OVA-conjugated nanoparticles (NP-OVA + CpG) or OVA-conjugated 
filariae and were restimulated with OVA or filarial lysate for 6 hours. (A) Restimulation with OVA. Pooled 
unstimulated responses for each group are shown on the left, and the OVA-specific CD4+ T cell response for 
each mouse is shown on the right in both panels. NP-OVA + CpG-vaccinated mice had a robust proportion of 
CD4+ and CD8+ T cells producing IFN-γ and TNF-α. Mice vaccinated with OVA-conjugated filariae had OVA-
specific CD4+ T cells producing IFN-γ and TNF-α but had undetectable levels of cytokine-secreting CD8+ T 
cells. The calculated effect size of OVA-worm (and OVA-NP-OVA + CpG adjuvancy were similar for worms 
and NP-OVA + CpG at 1.33 in the “CD4+ IFN-γ” group and 1.34 in the “CD4+ TNF-α” group compared to, 
0.99 and 1.2 in the “CD4+ IFN-γ” and “CD4+ TNF-α” groups, respectively. (B) Restimulation of splenocytes 
from mice immunized with NP-OVA + CpG with biotinylated OVA or native OVA. In contrast to native OVA 
protein, OVA biotinylated with NHS ester on its lysine residues did not activate CD8+ T cells isolated from NP-
OVA + CpG-vaccinated mice. (C) Restimulation of splenocytes from the filaria-OVA group with filarial lysate. 
Stimulation with filarial proteins induced the secretion of TNFα by CD4+ T cells and IFN-γ by CD8+ T cells 
to the same extent as stimulation with biotinylated OVA. For comparison with nematode (“worm”) lysate, the 
same worm-OVA values from A (green triangles) are plotted in C.
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the in vivo modification of cell surface amines with isothiocyanate or succinimide esters was minimally toxic to 
endothelial cells33,52 or had no adverse effect on dendritic cell migration53.
The immobilization of proteins on the surface of filariae is more complicated than fluorophore labeling 
because it requires two sequential and noninterfering, but kinetically efficient, reactions that are not toxic to the 
larvae. The prolonged exposure to low pH borate buffer needed to complete the second step of the bioorthogonal 
reaction between bifunctional linkers pre-introduced via NHS esters into the OVA (the aromatic hydrazine) and 
filarial proteins (aromatic aldehyde) was immediately toxic to larvae. Consequently, we used a sandwich tech-
nique, in which primary amines of both filariae and OVA were biotinylated with a succinimide ester biotin com-
pound and crosslinked to fluorescently labeled streptavidin (i.e., a bioorthogonal reaction between protein-bound 
biotin and streptavidin, commercially labeled with a fluorochrome). Similar to the direct fluorescent labeling of 
filariae, the biotinylation and subsequent crosslinking of streptavidin-OVA protein complexes had no immediate 
toxic effect on filarial behavior. The tetrameric streptavidin additionally multiplied the number of biotin-binding 
sites that were saturated in the third incubation step, the second step involving biotinylated OVA. We preferred 
the amine-conjugation chemistry for biotin crosslinking to OVA because, with 20 primary ε-amino lysine groups 
on a single OVA protein54, this approach maximizes the conjugation of multiple biotins to a single OVA protein. 
Consequently, the maximized conjugation facilitates the binding of multiple, potentially nonsaturated streptavi-
din molecules to OVA and the subsequent sandwich amplification of biotin-OVA deposits during the attachment 
of proteins to the larvae. In addition, amine acylation is a rapid, high-yield reaction55, which minimizes the 
time filariae spend outside their optimal culture medium environment. In contrast, thiol conjugation chemistry 
was not feasible in this approach because only 4 free cysteine amino acids are present in one OVA molecule54. 
Additionally, cysteines are buried within the protein, and additional denaturation and renaturation (solubiliza-
tion) steps are required55. However, the modification of overrepresented amino acids, such as lysine, increases the 
risk of destroying the epitope that is recognized by MHC molecules. Indeed, CD8+ T cell activation by OVA pro-
tein depends on the lysine in the OVA immunodominant SIINFEKL epitope being unmodified when presented in 
the context of MHC I molecules56. As expected, the OVA-induced CD8+ T cell response was lost after the biotiny-
lation of OVA. Nevertheless, the CD4-dependent Th1-type immune responses to OVA were not affected by bioti-
nylation because the ISQAVHAAHAEINEAGR peptide, the dominant OVA epitope, presented in the context 
of MHC II molecules57, is not modified by amine crosslinking chemistry. As anticipated, CD4+ but not CD8+ T 
lymphocytes from mice immunized with OVA-filaria could mount a Th1 immune response as determined by the 
production of IFN-γ or TNF-α in the biotinylated OVA-restimulated CD4+ T lymphocytes.
To date, the early stages of infection have not been imaged because filarial labeling is a technically challenging 
process49. Therefore, the presented method of intravital fluorescent labeling of infective larvae may become an 
indispensable tool for imaging the postinfection fate of filarial and possibly other parasites. Moreover, the biotiny-
lation of nematode proteins and subsequent labeling of live larvae with streptavidin opens imaging opportunities 
beyond the limits of fluorescence microscopy. As virtually any tracer can be attached to streptavidin without 
affecting its specificity58, this labeling method should be readily adapted for high resolution (˂1 mm) whole-body 
imaging techniques, such as magnetic resonance imaging (gadolinium-labeled streptavidin), ultrasound imaging 
(streptavidin-functionalized microbubbles), or positron emission tomography (124I and 64Cu-labeled streptavi-
din)59 allowing the visualization of, for example, the infection routes of intestinal parasites.
These experiments signal the potential of an alternative method for inducing an immune response against 
customized, non-nematode antigens. Immunization with OVA protein without an adjuvant does not provoke any 
immune response2,4. In contrast, the filaria-delivered antigen-induced an immune reaction and, unlike the bench-
mark nanoparticle-CpG vaccine, required no additional immunostimulatory adjuvant. The immune response 
induced by a dose of OVA on filaria that was one-fifth that of the nanoparticle vaccine demonstrated an evident 
dose-sparing effect of the worm-OVA vaccine. Importantly, Wolbachia, bacteria from the Rickettsia family, com-
bine the advantages of a robust live Th1 stimulant with the absence of direct pathogenicity to humans; they are 
obligate intracellular symbionts of invertebrates, and they cannot proliferate and survive in mammals60.
The use of filaria as an antigen and adjuvant carrier highlights a unique feature, specifically, antigen exposure 
in the context of a natural inflammatory environment. Hence, T cell stimulation by nonspecific filarial antigens 
may be advantageous when, for example, a response to a target antigen can benefit from complex local inflamma-
tion61 or the stimulation of innate immunity62. We have shown that with simple manipulations, filarial parasites 
can be recruited as natural vaccine carriers, integrating the targeting of the lymphatic system and adjuvant formu-
lation. Possible replacement of filaria larvae with nonpathogenic, free-living nematodes should increase the safety 
and, therefore, the applicability of this technique22.
The method of chemical immobilization of an antigen on filaria served the purpose of verifying the con-
cept. However, due to its effects on the structure of protein epitopes, it should be substituted with more neutral 
approaches, such as transgene expression in nematode cells. Additionally, the focus on Th1-type CD4+ T cell 
responses limits the conclusions that can be drawn from our study. For example, although Th1-type cellular 
immune responses have previously been observed in filariasis patients with filarial lymphedema63, infection with 
helminths is typically associated with polarization towards a classical Th2-type humoral response or, in some 
cases, a more refined CD4+ phenotype, such as Th9, Th17, Th22 or immunosuppressive Tregs (reviewed in64). 
However, the long-term presence of adult filariae and their microfilariae offspring in patients with filariasis would 
be expected to exert a different effect on the immune system than the model proposed here, where brief exposure 
to dying infective filaria larvae and their intracellular adjuvant is used to stimulate the immune system. Further 
experiments are needed to define the mechanism by which filarial larvae stimulate immunity against nonfilarial 
antigens and the resulting CD4+ T helper cell phenotype. However, we show here that harnessing the intrinsic 
adjuvancy of a nematode carrier offers an alternative method of immunization that might lead to the develop-
ment of vaccines producing pronounced cellular immunity.
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Materials and Methods
Ethics statement. This study was carried out in strict accordance with the Swiss Animal Protection Act, 
the ordinance on animal protection, the ordinance on animal experimentation, and the Veterinary Authority of 
the Institutional Animal Care and Use Committee of the University of Chicago. The protocols were approved by 
Commission de surveillance de l’Etat de Vaud. Animal immunization experiments were carried out in accordance 
with EU Directive 2010/63/UE and the French legislation “Décret no 2013-118, 1er février 2013, Ministère de l’Ag-
riculture, de l’Agroalimentaire et de la Forêt.” The animal experiments were approved by the Ethics Committee of 
the Museum National d’Histoire Naturelle (MNHN) and by the “Direction départementale de la cohésion sociale 
et de la protection des populations.”
Reagents. Endotoxin-free ovalbumin (OVA) and CpG-B 1826 were purchased from InvivoGen (San Diego, 
CA); fetal bovine serum (FBS), Dulbecco’s modified Eagle’s medium (DMEM), HEPES, penicillin/streptomy-
cin/amphotericin B solution (100×), FITC, 5 TRITC, and EZ-Link sulfo-NHS-biotin, Zeba Spin columns, 
DMSO (dimethylsulfoxide) were purchased from Thermo Fisher Scientific (Waltham, MA); the biotinylated 
anti-collagen IV antibody and Streptavidin-Alexa Fluor 488 and -Alexa Fluor 647, Alexa Fluor 647-NPs, Alexa 
Fluor 647 C2 Maleimide were from Invitrogen (Carlsbad, CA); Hartmann’s solution was from Braun (Melsungen, 
Germany); maleimide-DY-647 was from Dyomics (Jena, Germany); sulfo-S-HyNic and sulfo-S-4FB were from 
TriLink Biotechnologies (San Diego, CA); CpG-B 1826 from InvivoGen (San Diego, CA); Sephadex G-25 col-
umns were from GE Healthcare (Glattbrugg, Switzerland). Other common reagents were from Sigma-Aldrich 
(St Louis, MO).
Maintenance of L3 infective filariae. The L. sigmodontis life cycle was maintained as previously 
described65. Briefly, a patent filarial infection was established in gerbils (Meriones unguiculatus) at the MNHN 
laboratory in Paris, France. Infective third-stage larvae (L3) were isolated by dissection of the mite vector 
Ornithonyssus bacoti, counted, and placed in cell culture medium (H-DMEM; 4.5 g glucose/L, DMEM with 
25 mM HEPES, 400 U/ml penicillin, 400 U/ml streptomycin, 1 μg/ml amphotericin B, pH 7.5) before labeling 
under 5% CO2 at 37 °C.
Isolation of free-living (soil-derived) nematodes. Free-living nematodes, including plant-parasitic 
roundworms, were isolated from soil samples using the Baermann funnel method66. Soil samples were collected 
during the summer season from continuously monitored grassland that is not visited by livestock, pets, or wild 
animals. To remove large, insoluble particles, 100 g aliquots of the soil samples were mixed with 300 ml of deion-
ized water and passed through a funnel-shaped No. 20 sieve (850 μm mesh size). The same mesh sieve was placed 
within a larger funnel fitted with 5 cm of rubber tubing, which was sealed with a hemostat. A Kleenex tissue was 
placed on the screen, and deionized water was poured into the funnel until it covered approximately half of the 
fitted screen. Subsequently, soil samples were poured onto the screen, and nematodes were collected in the first 
50-ml fraction from the rubber tubing 48 hours later. Nematodes were spun down at 500 × g and hand-picked 
from the remaining 5 ml of water with a 200 μl pipette. Collected nematodes were kept at 4 °C, and prior to stain-
ing with TRITC, the nematodes were transferred to phosphate-buffered saline (PBS; pH 7.4).
Labeling of filarial L3 larvae and free-living nematodes with FITC, TRITC or EZ-Link 
sulfo-NHS-biotin. Stage 3 (L3) L. sigmodontis larvae were washed in 3 ml of Hartmann’s solution. Prior 
to labeling, 25 mg/ml of FITC or TRITC stock solution in DMSO, cell culture-grade) was diluted to 250 μg/ml 
in Hartmann’s solution and passed through a 0.45-μm filter. The EZ-Link sulfo-NHS-biotin stock solution was 
made by dissolving the EZ-Link sulfo-NHS-biotin directly in Hartmann’s solution at a concentration of 250 μg/
ml. Next, 0.5 ml of FITC-, TRITC-medium, or EZ-Link sulfo-NHS-biotin was immediately mixed with 100 μl of 
Hartmann’s solution containing 100 to 300 filarial larvae for 15 minutes. Later, larvae were washed three times in 
a new vial containing 3 ml of Hartmann’s solution and five times in H-DMEM with 20% FBS.
OVA labeling and bioorthogonal conjugation to filariae. Nanoparticle synthesis and conjugation with 
OVA. Thiol-immobilization of denatured OVA to nanoparticles. Pluronic-stabilized PPS-NPs were synthesized 
by emulsion polymerization and surface-functionalized, as previously described (7). Alexa 647-NPs were labeled 
with Alexa Fluor 647 C2 Maleimide, and free dye was removed at the end of the reaction by gel filtration through 
Sepharose CL6B exclusion matrix. For antigen conjugation, OVA and NPs were incubated for 6 h at room temper-
ature in the presence of guanidinium hydrochloride to expose by partial unfolding the free thiols on the protein.
Amine substitution with aromatic hydrazine (S-HyNic) and an aromatic aldehyde (S-4FB). For OVA thiol labe-
ling, 10 mg of protein was mixed with 6 M guanidine hydrochloride and 4 equivalents of DY-647-Maleimide 
that reacts with exposed free thiols. The fluorescently labeled OVA was dialyzed from guanidine HCl and 
unconjugated dye by size exclusion through a Sephadex G-25 column. For conjugation to filaria, water-soluble 
sulfo-S-HyNic and sulfo-S-4FB crosslinkers were used. All reactions were performed at room temperature. 
Briefly, 5 mg of previously fluorescently labeled OVA was mixed with a 10-fold molar excess of sulfo-S-HyNic 
in 100 mM phosphate buffer, 150 mM NaCl at pH 8.0. The protein was purified through a Zeba Spin column 
equilibrated in 100 mM phosphate buffer, 150 mM NaCl at pH 6.0, to remove any excess unbound crosslinker. 
In parallel, 30 filariae were labeled with 5 mg of sulfo-S-4FB in PBS, and the free crosslinker was removed with 5 
repeated H-DMEM washes. Once the OVA and filariae were functionalized, both components were mixed and 
left to react for 1 hour in 150 mM NaCl at pH 6.0 buffer. Filariae were then washed 5 times with 3 ml of H-DMEM 
supplemented with 20% FBS to remove free OVA protein followed by 2 washes with Hartmann’s solution and then 
imaged on a Leica fluorescence stereomicroscope.
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Streptavidin sandwich method. All reactions were performed at room temperature. For OVA amine modi-
fication with water-soluble EZ-Link sulfo-NHS-biotin, 10 mg of OVA protein was mixed with 10 molar equiva-
lents of biotinylation reagent in PBS (pH 7.5), and the reaction was continued for 2 hours at room temperature. 
Unconjugated biotin was removed from the solution by size exclusion through a Sephadex G-25 column. The 
same reagent was used to label filariae with biotin. Larvae were first washed with 3 changes of PBS and reacted 
for 15 minutes with 250 μg/ml freshly prepared EZ-Link sulfo-NHS-biotin in PBS. After 3 subsequent washes in 
Hartmann’s and 5 washes in H-DMEM supplemented with 20% serum, the larvae were incubated with 400 μg of 
Alexa 488-streptavidin for 10 minutes. After being washed 5 times with H-DMEM with 20% serum, larvae were 
washed twice with Hartmann’s solution and imaged on a Leica fluorescence stereomicroscope. Larvae were then 
reacted for 10 minutes with biotinylated OVA and washed 5 times with H-DMEM with 20% serum. After the fifth 
wash, the larvae were incubated with 400 μg/ml of Alexa 647-streptavidin in H-DMEM for 10 minutes. After being 
washed 5 times with H-DMEM with 20% serum, the larvae were washed twice with Hartmann’s solution and again 
imaged on a Leica fluorescence stereomicroscope in green (488 nm) and far-red (647 nm) channels to determine 
the amplification of fluorescent labeling of the filariae. The larvae were then incubated for a second time with 2 mg/
ml biotinylated OVA, washed 5 times with H-DMEM with 20% FBS, twice with Hartmann’s and injected into mice.
Densitometric determination of the filaria-bound OVA with Western blot. After being sandwich 
labeled with OVA-streptavidin, 60 filaria larvae were transferred to pure water and frozen at −20 °C. Thawed filar-
iae and serial dilutions of biotinylated OVA and pure OVA were lysed with the addition of 5 × SDS-PAGE sample 
buffer (350 mM Tris, pH 6.8, 10% SDS, 0.5 M DDT, 50% glycerol, 10 mg/ml bromphenol blue) supplemented with 
10% Triton-X-100 and 25 mM EDTA. Each filarial sample was sonicated until it boiled, cooled to room tempera-
ture, and centrifuged at maximum speed for 5 minutes. The soluble fraction of nematode proteins was collected, 
and together with two biotinylated OVA serial dilution standards, they were heated for 7 minutes at 95 °C. After 
cooling to room temperature, samples were supplemented with 200 mM iodoacetamide and loaded into wells of 
the same stacking gel. Samples were resolved on 12% acrylamide gel and transferred with semi-dry blotting to a 
0.2 µm 100% nitrocellulose membrane (Biorad). The membrane was blocked at 42 °C for 1 hour with 5% bovine 
serum albumin in Tris-buffered saline (TBS) containing 0.1% Tween- 20. The membrane was incubated with 
10 mg/ml HRP-conjugated streptavidin (ThermoFisher), and the OVA bands were visualized on photographic 
film with an ECL reagent kit (Pierce). Densitometric measurements were performed on nonsaturated bands, and 
the filaria-derived OVA concentration was calculated from a serial dilution of biotinylated OVA reference bands.
Larval inoculation and whole-mount tissue imaging. Approximately 30 fluorescently labeled larvae in 
30 μl of Hartmann’s solution were loaded into U-100 insulin syringes from the plunger side and allowed to settle 
at the needle outlet for 10 minutes. Twenty microliters of the larval suspension were then injected intradermally 
into the top dorsal region of each mouse’s ear. In total, 14 mice were used in these experiments.
Whole-mount staining and imaging were performed essentially as described before34,67. Mice were fixed by 
intracardiac perfusion. Blood was first removed at a constant pressure of 100 mm Hg with 20 ml of Ringer-lactate 
solution (Hartmann’s solution) supplemented with 25 mM HEPES and 0.1% glucose. The mice were then per-
fused with 25 ml of zinc fixer (39 mM Zn(CF3COO)2, 37 mM ZnCl2, 4.5 mM CaCl2, 60 mM glycine, pH 667). 
Ears and lymph nodes were dissected and placed in ice-cold zinc fixer for at least 24 hours. Later, ventral skin, 
muscle, and cartilage were removed from the ear, and dorsal skin and lymph nodes were postfixed for another 
24 hours in zinc fixer with 0.1% Triton-100. Tissues were then washed twice in TBS (25 mM Tris, 140 mM NaCl, 
pH 7.5), briefly incubated in 0.5% casein in TBS, and labeled for 24 hours with 10 μg/ml biotinylated primary 
anti-collagen IV antibody. After being washed in TBS-0.1% Tween® 20, the tissues were incubated with Alexa 
488- or Alexa 647-streptavidin for 24 hours. Washed tissues were clarified in Murray’s clear (1:2 benzyl alcohol/
benzyl benzoate68), mounted on a glass slide, and imaged using a Leica SP5 confocal microscope equipped with 
a white-spectrum laser or an Olympus IX82 microscope equipped with an Olympus disk spinning unit, Spectra 
X light engine from Lumencor and Orca-Flash 4.0 v2 from Hamamatsu. Optical sections, maximum intensity 
projections (MIPs), or overlay surface masks were generated from image stacks using Imaris 7.1 (Bitplane AG, 
Zürich, Switzerland).
Live imaging of larvae in the skin. The staining of ear intravital skin was performed as previously 
described34. Mice were anesthetized with 3% induction and 1.5% maintenance concentrations of isoflurane. 
Ventral skin, muscle, and cartilage of the ear were partially removed, leaving only the top fragment of the ventral 
skin attached to the dorsal skin flap. The dorsal skin was then stained for 30 minutes with 10 μg/ml biotinylated 
anti-collagen IV antibody or anti-Lyve1 antibody, and an anti-podoplanin antibody in Hartmann’s solution sup-
plemented with 2 mg/ml aprotinin. After the tissue was washed 5 times with Hartmann’s solution, the primary 
antibodies were detected with 10 μg/ml fluorescent streptavidin or the appropriate fluorescent secondary antibod-
ies. Thirty larvae were then either applied to the prelabeled exposed ear dermis or injected intradermally in the 
top dorsal skin located above the collagen IV-stained dorsal skin. Immediately after inoculation, filaria larvae and 
stained tissue were imaged every 30 seconds using a Leica M205 FA fluorescent stereomicroscope.
Vaccinations. C57BL/6 mice were injected subcutaneously in a footpad with 35 filariae conjugated to OVA (4 µg 
dose, 6 mice). As a positive control, another group of mice received an intradermal injection of 20 µg of OVA conjugated 
to synthetic nanoparticles with 2.5 µg of CpG-B 1826 (5 mice) as an adjuvant according to previously published proto-
cols4, and 4 mice served as negative controls were injected with PBS or 20 µg of OVA. Mice received a boost of the same 
vaccine formulations 1, 2, and 3 months later. One month after the last boost, mice were euthanized, and spleens were 
collected and passed through a 60-µm cell strainer for further T cell restimulation.
1 0Scientific RepoRtS |         (2020) 10:1055  | https://doi.org/10.1038/s41598-020-57995-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
Antigen-specific restimulation. Splenocytes were seeded at 3 × 106 cells/well in round-bottom 96-well 
tissue culture plates in Iscove’s Modified Dulbecco’s medium supplemented with 10% FBS and 1% penicillin/
streptomycin. Cells were restimulated with 100 μg/ml OVA grade VI (CpG group), or where indicated, with bioti-
nylated OVA (NP-OVA CpG vaccination group) or filariae lysate (30 filariae frozen and sonicated on ice in 100 μl 
of cell culture medium). Pooled samples from mice in each group were left unstimulated to measure background 
levels of cytokines. After 3 hours, the cells were treated with brefeldin A (5 μg/ml) to block cytokine secretion and 
then incubated for another 3 hours. The cells were stained according to standard intracellular cytokine staining 
protocols and were analyzed for cytokine production by flow cytometry4.
Statistical analysis. Statistical comparisons of 2 treatment groups relative to the control (naive mice) group 
were made using one-way ANOVA followed by Dunnett’s post hoc test (Fig. 3 and Supplementary Fig. 2). An 
unpaired t-test with Welsh’s correction for unequal variance was used when comparing two groups. Differences, 
where p-values were less than 5%, are joined by a vertical line. Tests were computed as two-tailed assumptions. 
The effect sizes were calculated for the comparisons between NP-OVA + CpG and worms relative to the naive 
control mice (Fig. 3A). The population standard deviation was estimated from the pooled standard deviations of 





. Statistical analyses were performed 
using GraphPad Prism (ver. 7.1 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com).
Data availability
All data generated or analyzed during this study are included in this published article (and its Supplementary 
Information files). Source datasets generated and/or analyzed during the current study are available from Figshare 
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